MANGALAM DRUGS AND ORGANICS
|
MANGALAM DRUGS AND ORGANICS Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity - Authorised | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr |
Equity - Issued | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity Paid Up | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹136 Cr | ₹135 Cr | ₹115 Cr | ₹88 Cr | ₹80 Cr |
Securities Premium | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr | ₹22 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹103 Cr | ₹102 Cr | ₹82 Cr | ₹55 Cr | ₹47 Cr |
General Reserves | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹136 Cr | ₹135 Cr | ₹115 Cr | ₹88 Cr | ₹80 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹152 Cr | ₹151 Cr | ₹131 Cr | ₹104 Cr | ₹96 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹19 Cr | ₹25 Cr | ₹6.63 Cr | ₹3.91 Cr | ₹8.10 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹25 Cr | ₹31 Cr | ₹13 Cr | ₹3.91 Cr | ₹8.10 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-6.26 Cr | ₹-6.62 Cr | ₹-5.91 Cr | - | - |
Unsecured Loans | - | ₹0.25 Cr | ₹0.25 Cr | ₹0.26 Cr | ₹0.50 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | ₹0.25 Cr | ₹0.25 Cr | ₹0.26 Cr | ₹0.50 Cr |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹15 Cr | ₹13 Cr | ₹14 Cr | ₹12 Cr | ₹14 Cr |
Deferred Tax Assets | - | ₹0.73 Cr | ₹1.11 Cr | ₹0.34 Cr | ₹1.60 Cr |
Deferred Tax Liability | ₹15 Cr | ₹14 Cr | ₹15 Cr | ₹13 Cr | ₹16 Cr |
Other Long Term Liabilities | ₹9.03 Cr | ₹9.15 Cr | ₹3.19 Cr | ₹0.80 Cr | ₹1.95 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹42 Cr | ₹48 Cr | ₹24 Cr | ₹17 Cr | ₹25 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹97 Cr | ₹55 Cr | ₹43 Cr | ₹57 Cr | ₹32 Cr |
Sundry Creditors | ₹97 Cr | ₹55 Cr | ₹43 Cr | ₹57 Cr | ₹32 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹17 Cr | ₹25 Cr | ₹14 Cr | ₹10 Cr | ₹7.30 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹0.26 Cr | ₹10 Cr | ₹0.72 Cr | - | - |
Interest Accrued But Not Due | ₹0.04 Cr | ₹0.05 Cr | ₹0.06 Cr | ₹0.20 Cr | ₹0.10 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹17 Cr | ₹15 Cr | ₹13 Cr | ₹9.99 Cr | ₹7.20 Cr |
Short Term Borrowings | ₹50 Cr | ₹47 Cr | ₹51 Cr | ₹42 Cr | ₹51 Cr |
Secured ST Loans repayable on Demands | ₹49 Cr | ₹47 Cr | ₹50 Cr | ₹42 Cr | ₹47 Cr |
Working Capital Loans- Sec | ₹49 Cr | ₹47 Cr | ₹50 Cr | ₹42 Cr | ₹47 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-49 Cr | ₹-47 Cr | ₹-49 Cr | ₹-42 Cr | ₹-43 Cr |
Short Term Provisions | ₹1.72 Cr | ₹3.27 Cr | ₹0.40 Cr | ₹0.83 Cr | ₹0.59 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.38 Cr | ₹2.27 Cr | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹1.34 Cr | ₹1.00 Cr | ₹0.40 Cr | ₹0.83 Cr | ₹0.59 Cr |
Total Current Liabilities | ₹165 Cr | ₹130 Cr | ₹109 Cr | ₹109 Cr | ₹91 Cr |
Total Liabilities | ₹360 Cr | ₹328 Cr | ₹264 Cr | ₹231 Cr | ₹211 Cr |
ASSETS | |||||
Gross Block | ₹241 Cr | ₹224 Cr | ₹197 Cr | ₹171 Cr | ₹165 Cr |
Less: Accumulated Depreciation | ₹99 Cr | ₹89 Cr | ₹79 Cr | ₹70 Cr | ₹62 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹142 Cr | ₹135 Cr | ₹118 Cr | ₹101 Cr | ₹103 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹6.40 Cr | ₹0.18 Cr | ₹4.87 Cr | ₹1.24 Cr | ₹0.20 Cr |
Non Current Investments | ₹0.00 Cr | ₹0.00 Cr | ₹0.22 Cr | ₹0.22 Cr | ₹0.24 Cr |
Long Term Investment | ₹0.00 Cr | ₹0.00 Cr | ₹0.22 Cr | ₹0.22 Cr | ₹0.24 Cr |
Quoted | - | - | ₹0.12 Cr | ₹0.12 Cr | ₹0.12 Cr |
Unquoted | ₹0.00 Cr | ₹0.11 Cr | ₹0.11 Cr | ₹0.11 Cr | ₹0.12 Cr |
Long Term Loans & Advances | ₹1.19 Cr | ₹2.72 Cr | ₹5.79 Cr | ₹8.96 Cr | ₹2.38 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹153 Cr | ₹143 Cr | ₹130 Cr | ₹111 Cr | ₹106 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹137 Cr | ₹117 Cr | ₹59 Cr | ₹65 Cr | ₹73 Cr |
Raw Materials | ₹30 Cr | ₹51 Cr | ₹27 Cr | ₹37 Cr | ₹28 Cr |
Work-in Progress | ₹64 Cr | ₹39 Cr | ₹17 Cr | ₹14 Cr | ₹15 Cr |
Finished Goods | ₹38 Cr | ₹26 Cr | ₹14 Cr | ₹13 Cr | ₹30 Cr |
Packing Materials | ₹0.13 Cr | ₹0.19 Cr | ₹0.22 Cr | ₹0.23 Cr | ₹0.30 Cr |
Stores Ā and Spare | - | - | - | - | - |
Other Inventory | ₹4.77 Cr | ₹0.91 Cr | - | - | - |
Sundry Debtors | ₹47 Cr | ₹46 Cr | ₹54 Cr | ₹40 Cr | ₹18 Cr |
Debtors more than Six months | ₹0.31 Cr | ₹0.11 Cr | ₹0.05 Cr | - | - |
Debtors Others | ₹46 Cr | ₹46 Cr | ₹54 Cr | ₹40 Cr | ₹18 Cr |
Cash and Bank | ₹2.69 Cr | ₹1.96 Cr | ₹0.59 Cr | ₹1.63 Cr | ₹1.43 Cr |
Cash in hand | ₹0.04 Cr | ₹0.12 Cr | ₹0.06 Cr | ₹0.07 Cr | ₹0.05 Cr |
Balances at Bank | ₹2.65 Cr | ₹1.84 Cr | ₹0.54 Cr | ₹1.56 Cr | ₹1.39 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹3.62 Cr | ₹3.79 Cr | ₹3.66 Cr | ₹2.48 Cr | ₹2.39 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹1.87 Cr | ₹2.05 Cr | ₹1.90 Cr | ₹0.71 Cr | ₹0.60 Cr |
Other current_assets | ₹1.75 Cr | ₹1.74 Cr | ₹1.77 Cr | ₹1.77 Cr | ₹1.79 Cr |
Short Term Loans and Advances | ₹16 Cr | ₹16 Cr | ₹17 Cr | ₹10 Cr | ₹10 Cr |
Advances recoverable in cash or in kind | ₹3.76 Cr | ₹7.40 Cr | ₹1.22 Cr | - | - |
Advance income tax and TDS | - | - | ₹0.54 Cr | - | ₹1.57 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹13 Cr | ₹8.29 Cr | ₹15 Cr | ₹10 Cr | ₹8.57 Cr |
Total Current Assets | ₹207 Cr | ₹185 Cr | ₹134 Cr | ₹119 Cr | ₹105 Cr |
Net Current Assets (Including Current Investments) | ₹41 Cr | ₹55 Cr | ₹25 Cr | ₹9.71 Cr | ₹14 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹360 Cr | ₹328 Cr | ₹264 Cr | ₹231 Cr | ₹211 Cr |
Contingent Liabilities | ₹26 Cr | ₹46 Cr | ₹31 Cr | ₹7.28 Cr | ₹6.77 Cr |
Total Debt | ₹75 Cr | ₹79 Cr | ₹64 Cr | ₹50 Cr | ₹63 Cr |
Book Value | - | 95.12 | 82.63 | 65.67 | 60.44 |
Adjusted Book Value | 96.00 | 95.12 | 82.63 | 65.67 | 60.44 |
Compare Balance Sheet of peers of MANGALAM DRUGS AND ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM DRUGS AND ORGANICS | ₹161.2 Cr | -0.4% | -21.3% | -8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
MANGALAM DRUGS AND ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM DRUGS AND ORGANICS | -0.4% |
-21.3% |
-8.1% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses